Stay updated on Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial

Sign up to get notified when there's something new on the Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2 instead of v3.0.1, and the Back to Top element was removed; overall content remains essentially the same.
    Difference
    0.8%
    Check dated 2025-09-14T00:38:25.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The recruitment status for Actinium Pharmaceuticals has been updated to 'Unknown status', indicating a significant change in the information provided about the clinical trial. Additionally, the version of the document has been revised from v3.0.0 to v3.0.1.
    Difference
    3%
    Check dated 2025-09-06T21:27:09.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, while removing specific location details and previous status verifications.
    Difference
    12%
    Check dated 2025-08-30T15:58:59.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.
    Difference
    0.3%
    Check dated 2025-08-16T12:47:36.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.3%
    Check dated 2025-08-09T08:09:27.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version (v2.16.10) and a change in the status of a service related to Actinium Pharmaceuticals, which is now listed as 'Unknown status'.
    Difference
    6%
    Check dated 2025-08-02T04:14:36.000Z thumbnail image

Stay in the know with updates to Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial page.